Surface Oncology, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q1 2017 to Q2 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Surface Oncology, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q1 2017 to Q2 2023.
- Surface Oncology, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending June 30, 2023 was -$27.8M, a 9.31% decline year-over-year.
- Surface Oncology, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending June 30, 2023 was -$91.6M, a 42.8% decline year-over-year.
- Surface Oncology, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$64.4M, a 18.2% increase from 2021.
- Surface Oncology, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$78.7M, a 233% decline from 2020.
- Surface Oncology, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2020 was $59.2M.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)